0001437749-26-003904
SEC filingArt's-Way Manufacturing Co., Inc. (ARTW) reported FY 2025 revenues of $23.0M, with gross profit of $6.3M reflecting a gross margin of 27.4%. Operating income reached $289K, supported by total expenses of $6.0M including engineering at $344K, selling at $1.4M, and general/administrative at $4.2M. Other nonoperating income of $1.5M offset interest expense of $367K, leading to pretax income of $1.4M and net income of $1.0M after $402K tax expense. Balance sheet shows total assets of $22.5M, with inventories at $11.7M and total current assets $14.8M against current liabilities of $6.4M, yielding stockholders' equity of $13.3M. Cash flow from operations was negative at -$904K due to $1.7M unfavorable contracts in progress, offset by $1.4M inventory reduction; financing provided $1.5M net, including $1.3M line of credit increase, resulting in net cash increase of $3K to $4K ending balance. No discontinued operations or segment breakdowns disclosed. Weighted average shares were 5.1M, with EPS at $0.
Art's-Way Manufacturing Co., Inc. reported FY 2025 ending November 30, 2025, with revenues of $23.0M and cost of goods sold at $16.7M, yielding gross profit of $6.3M. Operating expenses totaled $6.0M, comprising engineering $344K, selling $1.4M, and general/administrative $4.2M, resulting in operating income of $289K. Other income included $1.5M nonoperating income against $367K interest expense, for pretax income of $1.4M. After $402K income tax expense, net income from continuing operations was $1.0M, with no discontinued operations. Total assets stood at $22.5M, liabilities $9.2M, and stockholders' equity $13.3M. No prior year figures disclosed in filing for direct YoY comparison. Weighted average shares basic and diluted: 5.1M, EPS $0.
Revenues totaled $23.0M for FY 2025. No segment breakdowns, geographic mix, or specific growth drivers disclosed in the provided filing data. Gross profit of $6.3M represented 27.4% margin over $16.7M cost of goods sold. Filing contains no MD&A details on revenue sources or changes from prior periods.
Gross margin was 27.4% ($6.3M gross profit / $23.0M revenue). Operating margin measured 1.3% ($289K / $23.0M revenue). Total operating expenses of $6.0M slightly exceeded gross profit, limiting operating profitability. No prior year margins available for trend analysis. Engineering expenses at $344K, selling $1.4M, G&A $4.2M. No disclosed changes in cost structure.
Operating cash flow was -$904K, despite $1.0M net income, due to -$1.7M contracts in progress, partially offset by $1.4M inventories reduction and $792K depreciation. Investing cash outflow -$580K from $628K PPE purchases, net of $47K asset sales. Financing inflow $1.5M via $1.3M line of credit, $517K term debt proceeds, offset by payments. Net cash increase $3K; ending cash $4K (begin $1K implied). Balance sheet: current assets $14.8M (inventories $11.7M), current liabilities $6.4M (line of credit $3.3M), long-term debt $2.3M, total debt exposure evident. Equity $13.3M with retained earnings $8.4M.
No management guidance, strategic priorities, or risk factors explicitly disclosed in the provided filing excerpt. Commitments noted in Notes 8, 9, 10, 17, but no details provided.